UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients

AIDS (London), 2014-02, Vol.28 (4), p.467-476

2014

Volltextzugriff (PDF)

Prevalence and risk factors of frailty among adults living with HIV aged 70 years or older

AIDS (London), 2023-01, Vol.37 (1), p.183-189

2023

Volltextzugriff (PDF)

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France

AIDS (London), 2009-03, Vol.23 (6), p.717-724

2009

Volltextzugriff (PDF)

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

AIDS (London), 2012-01, Vol.26 (3), p.303-314

2012

Volltextzugriff (PDF)

Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use

AIDS (London), 2012-01, Vol.26 (2), p.207-215

2012

Volltextzugriff (PDF)

The proportion of CD57+ cells among effector CD8+ T cells is lower HIV controllers compared to ART treated patients

AIDS (London), 2019-08

2019

Volltextzugriff (PDF)

Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients

AIDS (London), 2015-09, Vol.29 (14), p.1821-1830

ANRS CO13 HEPAVIH Cohort

2015

Volltextzugriff (PDF)

Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials

AIDS (London), 2019-11, Vol.33 (13), p.2061-2071

2019

Volltextzugriff (PDF)

The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients

AIDS (London), 2019-11, Vol.33 (14), p.2137-2147

2019

Volltextzugriff (PDF)

Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients

AIDS (London), 2015-09, Vol.29 (14), p.1821-1830

2015

Volltextzugriff (PDF)

Natural history of HIV-control since seroconversion

AIDS (London), 2013-09, Vol.27 (15), p.2451-2460

2013

Volltextzugriff (PDF)

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time

AIDS (London), 2006-01, Vol.20 (2), p.159-170

2006

Volltextzugriff (PDF)

Elevated IP10 levels are associated with immune activation and low CD4 super(+) T-cell counts in HIV controller patients

AIDS (London), 2014-02, Vol.28 (4), p.467-476

2014

Volltextzugriff (PDF)

MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection

AIDS (London), 2013-07, Vol.27 (11), p.1707-1716

2013

Volltextzugriff (PDF)

Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

AIDS (London), 2001-04, Vol.15 (6), p.665-673

2001

Volltextzugriff (PDF)

Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02

AIDS (London), 2011-07, Vol.25 (11), p.1371-1377

2011

Volltextzugriff (PDF)

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?

AIDS (London), 2015-11, Vol.29 (17), p.2323-2333

2015

Volltextzugriff (PDF)

Does pregnancy affect the early response to cART?

AIDS (London), 2013-01, Vol.27 (3), p.357-367

2013

Volltextzugriff (PDF)

No evidence of a change in HIV-1 virulence since 1996 in France

AIDS (London), 2009-06, Vol.23 (10), p.1261-1267

2009

Volltextzugriff (PDF)

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

AIDS (London), 2003-12, Vol.17 (18), p.2635-2643

2003

Volltextzugriff (PDF)

Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial

AIDS (London), 2012-09, Vol.26 (15), p.1895-1905

2012

Volltextzugriff (PDF)

CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters

AIDS (London), 2011-03, Vol.25 (6), p.819-823

2011

Volltextzugriff (PDF)

Does transient HAART during primary HIV-1 infection lower the virological set-point?

AIDS (London), 2004-12, Vol.18 (18), p.2361-2369

2004

Volltextzugriff (PDF)

Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

AIDS (London), 2000-01, Vol.14 (2), p.123-131

2000

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionEZB Electronic Journals Library

Zeitschrift / SerieAids

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Infectious Diseases
(27)
Humans
(25)
Immunology
(25)
Aids/hiv
(24)
Biological And Medical Sciences
(24)
Life Sciences & Biomedicine
(24)
Medical Sciences
(24)
Science & Technology
(24)
Virology
(24)
Human Viral Diseases
(20)
Viral Diseases
(20)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(20)
Female
(19)
Male
(19)
Adult
(17)
Human Immunodeficiency Virus 1
(16)
Immunodeficiencies
(16)
Immunodeficiencies. Immunoglobulinopathies
(16)
Immunopathology
(16)
Hiv Infections - Drug Therapy
(15)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Ovid SocietyJournals and Single Titles
(34)
NUS Single-Journal Subscriptions
(34)
IngentaConnect Journals
(32)
Ingenta
(32)
MEDLINE
(25)

Menü

Weitere Dienste

Einstellungen

Elevated IP10 levels are associated with immune activation and low CD4+ T-cell counts in HIV controller patients

Prevalence and risk factors of frailty among adults living with HIV aged 70 years or older

Stable frequency of HIV-1 transmitted drug resistance in patients at the time of primary infection over 1996-2006 in France

Frailty and pre-frailty phenotypes increase the odds of abnormal cognitive impairment screens in people living with HIV

Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment

Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use

The proportion of CD57+ cells among effector CD8+ T cells is lower HIV controllers compared to ART treated patients

Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients

Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials

The proportion of CD57+ cells among effector CD8+ T cells is lower in HIV controllers compared with antiretroviral therapy-treated patients

Regression of liver stiffness after sustained hepatitis C virus (HCV) virological responses among HIV/HCV-coinfected patients

Natural history of HIV-control since seroconversion

HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time

Elevated IP10 levels are associated with immune activation and low CD4 super(+) T-cell counts in HIV controller patients

MHC-driven HIV-1 control on the long run is not systematically determined at early times post-HIV-1 infection

Proviral HIV-1 DNA in subjects followed since primary HIV-1 infection who suppress plasma viral load after one year of highly active antiretroviral therapy

Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?

Does pregnancy affect the early response to cART?

No evidence of a change in HIV-1 virulence since 1996 in France

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

Continuous versus intermittent treatment strategies during primary HIV-1 infection: the randomized ANRS INTERPRIM Trial

CD4 cell eligibility thresholds: an analysis of the time to antiretroviral treatment in HIV-1 seroconverters

Does transient HAART during primary HIV-1 infection lower the virological set-point?

Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

Aktive Filter

Suchergebnisse filtern